PharmaShots | Incisive News in 3 Shots

Subscribe Now

NMPA Granted Marketing Approval

Innovent and Lilly's Halpryza (biosimilar- rituximab) Receive NMPA's Approval in China

Innovent and Lilly's Halpryza (biosimilar- rituximab) Receive NMPA's Approval in China

October 12, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us